DRKS00010435已完成不适用
Integrated human papillomavirus (HPV) DNA as individualized biomarker for the detection of recurrent cervical pre-cancer in post-treatment surveillance - HPV-INT-CX
Klinik für Frauenheilkunde und GeburtshilfeAbteilung FrauenheilkundeUniversitätsklinikum Jena0 个研究点目标入组 649 人开始时间: 2016年5月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 649
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •Patients with histologic confirmed HPV16 or HPV18 positive CIN3
- •Informed consent
排除标准
- •Re-conisation
研究者
相似试验
已完成
不适用
Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical NeoplasiaCervical Intraepithelial NeoplasiaNCT02198365Cathay General Hospital250
已完成
不适用
Human papillomavirus detection, genotyping and integration in uterine cervical neoplasia patients.uterine cervical intraepithelial neoplasia, and cervical cancerJPRN-UMIN000012402Dpt. of Obstetrics and Gynecology Osaka Medical College300
已完成
不适用
Human papillomavirus detection, genotyping and integration in uterine cervical neoplasia patients.JPRN-UMIN000012406Dpt. of Obstetrics and Gynecology Osaka Medical College300
进行中（未招募）
不适用
Determination of the human papillomavirus (HPV)-specific antibody status in oral fluids of individuals vaccinated with a quadrivalent HPV vaccineEUCTR2008-008605-22-ATMedizinische Universität Wien, Univ.Klinik für Dermatologie
尚未招募
不适用
Feasibility of HPV DNA and vaginal infection detection by self testKCT0007456Korea Cancer Center Hospital316